Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products. Final rule
- PMID: 27192730
Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products. Final rule
Abstract
The Food and Drug Administration (FDA) is issuing this final rule to deem products meeting the statutory definition of "tobacco product,'' except accessories of the newly deemed tobacco products, to be subject to the Federal Food, Drug, and Cosmetic Act (the FD&C Act), as amended by the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act). The Tobacco Control Act provides FDA authority to regulate cigarettes, cigarette tobacco, roll-your-own tobacco, smokeless tobacco, and any other tobacco products that the Agency by regulation deems to be subject to the law. With this final rule, FDA is extending the Agency's "tobacco product'' authorities in the FD&C Act to all other categories of products that meet the statutory definition of "tobacco product" in the FD&C Act, except accessories of such newly deemed tobacco products. This final rule also prohibits the sale of "covered tobacco products" to individuals under the age of 18 and requires the display of health warnings on cigarette tobacco, roll-your own tobacco, and covered tobacco product packages and in advertisements. FDA is taking this action to reduce the death and disease from tobacco products. In accordance with the Tobacco Control Act, we consider and intend the extension of our authorities over tobacco products and the various requirements and prohibitions established by this rule to be severable.
Similar articles
-
Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents. Final rule.Fed Regist. 2010 Mar 19;75(53):13225-32. Fed Regist. 2010. PMID: 20383919
-
Further amendments to general regulations of the Food and Drug Administration to incorporate tobacco products. Final rule.Fed Regist. 2012 Feb 2;77(22):5171-6. Fed Regist. 2012. PMID: 22359802
-
Required warnings for cigarette packages and advertisements. Final rule.Fed Regist. 2011 Jun 22;76(120):36628-777. Fed Regist. 2011. PMID: 21696017
-
Research gaps related to tobacco product marketing and sales in the Family Smoking Prevention and Tobacco Control Act.Nicotine Tob Res. 2012 Jan;14(1):43-53. doi: 10.1093/ntr/ntr098. Epub 2011 Jun 20. Nicotine Tob Res. 2012. PMID: 21690316 Review.
-
Tobacco packaging and labeling policies under the U.S. Tobacco Control Act: research needs and priorities.Nicotine Tob Res. 2012 Jan;14(1):62-74. doi: 10.1093/ntr/ntr182. Epub 2011 Oct 29. Nicotine Tob Res. 2012. PMID: 22039072 Free PMC article. Review.
Cited by
-
Patterns, clusters, and transitions in U.S. state ENDS policy implementation: 2010-2020.PLOS Glob Public Health. 2024 Nov 13;4(11):e0003636. doi: 10.1371/journal.pgph.0003636. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39536032 Free PMC article.
-
Associations of e-cigarette advertising exposure with curiosity and susceptibility among U.S. adolescents: National Youth Tobacco Surveys, 2014-2020.PLoS One. 2024 Sep 20;19(9):e0303903. doi: 10.1371/journal.pone.0303903. eCollection 2024. PLoS One. 2024. PMID: 39302930 Free PMC article.
-
Lessons for cannabinoid regulation from electronic nicotine delivery system product regulation.Health Aff Sch. 2024 Aug 16;2(8):qxae101. doi: 10.1093/haschl/qxae101. eCollection 2024 Aug. Health Aff Sch. 2024. PMID: 39206436 Free PMC article.
-
E-Cigarette Characteristics and Cigarette Cessation Among Adults Who Use E-Cigarettes.JAMA Netw Open. 2024 Aug 1;7(8):e2423960. doi: 10.1001/jamanetworkopen.2024.23960. JAMA Netw Open. 2024. PMID: 39088219 Free PMC article.
-
The role of β-Nicotyrine in E-Cigarette abuse liability I: Drug Discrimination.bioRxiv [Preprint]. 2024 Jul 16:2024.07.12.603310. doi: 10.1101/2024.07.12.603310. bioRxiv. 2024. PMID: 39071347 Free PMC article. Preprint.
MeSH terms
LinkOut - more resources
Full Text Sources

